Tandem Diabetes Care Aktie [WKN DE: A1W8XG / ISIN: US8753721047]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Tandem Diabetes Care Inc

13.12.22		Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical (Businesswire)
16.11.22		Tandem Diabetes Care Earns Great Place to Work Certification™ (Businesswire)
10.11.22		Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology (Businesswire)
08.11.22		Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
02.11.22		Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
27.10.22		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
04.10.22		Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 (Businesswire)
22.08.22		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
18.08.22		Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App (Businesswire)
03.08.22		Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
21.07.22		Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical (Businesswire)
12.07.22		Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022 (Businesswire)
16.06.22		Tandem Diabetes Care Welcomes Two New Members to Board of Directors (Businesswire)
06.06.22		Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes (Businesswire)
18.05.22		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation (Businesswire)
04.05.22		Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
27.04.22		Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults (Businesswire)
11.04.22		Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022 (Businesswire)
07.03.22		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation (Businesswire)
28.06.21		Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations (Businesswire)
05.05.21		Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance (Businesswire)
03.05.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
06.04.21		Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021 (Businesswire)
03.03.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
01.03.21		Tandem Diabetes Care Appoints Leading Artificial Pancreas Researcher Dr. Jordan Pinsker as Medical Director (Businesswire)
24.02.21		Tandem Diabetes Care Announces Fourth Quarter and Full Year 2020 Financial Results and 2021 Financial Guidance (Businesswire)
16.02.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
19.01.21		Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 (Businesswire)
14.12.20		Tandem Diabetes Care Appoints Raj Sodhi to Board of Directors (Businesswire)
23.11.20		Tandem Diabetes Care Announces Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
05.11.20		Tandem Diabetes Care Announces Third Quarter 2020 Financial Results and Updated Full Year 2020 Sales Guidance (Businesswire)
30.10.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
08.10.20		Tandem Diabetes Care to Announce Third Quarter 2020 Financial Results on November 5, 2020 (Businesswire)
02.09.20		Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations (Businesswire)
27.08.20		Tandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
29.07.20		Tandem Diabetes Care Appoints Peyton Howell to Board of Directors (Businesswire)
09.07.20		Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement (Businesswire)
08.07.20		JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community (Businesswire)
07.07.20		Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020 (Businesswire)
24.06.20		Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes (Businesswire)
17.06.20		Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
13.06.20		Tandem Diabetes Care Presents Positive Real-world Data from Automated Insulin Delivery Systems at American Diabetes Association Scientific Sessions (Businesswire)
04.06.20		Tandem Diabetes Care Appoints Dr. Kathleen McGroddy-Goetz to Board of Directors (Businesswire)
29.05.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
18.05.20		Tandem Diabetes Care to Hold Virtual-Only 2020 Annual Meeting of Stockholders (Businesswire)
13.05.20		Tandem Diabetes Care Announces Pricing of $250.0 Million of Convertible Senior Notes Due 2025 (Businesswire)
12.05.20		Tandem Diabetes Care Announces Proposed Offering of $250.0 Million of Convertible Senior Notes Due 2025 (Businesswire)
07.05.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
30.04.20		Tandem Diabetes Care Announces First Quarter 2020 Financial Results (Businesswire)
09.04.20		Tandem Diabetes Care to Announce First Quarter 2020 Financial Results on April 30, 2020 (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Ripple Kurs Prognose: Ist der Boden erreicht und folgt jetzt ein neuer Bullrun?

Kursrakete gezündet? VanEck sieht Solana auf 520 Dollar steigen

NVIDIA-Aktie dennoch tiefer: NVIDIA-Bilanz besser als erhofft - Prognose offenbar höher erwartet

Rheinmetall-Aktie klettert dank Morgan Stanley und übersteigt erstmals 1.000-Euro-Marke

Swiss Re-Aktie legt zu: Swiss Re hebt nach Milliardengewinn Dividende an - Optimistischer Ausblick für 2025

AIXTRON-Aktie zweistellig tiefer: AIXTRON senkt Prognose - Margenrückgang und schwächerer Auftragseingang

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	02.03.2025 01:15
Kaufwert:	EUR
	Hinzufügen Speichern